Back

Cause and risk factors for readmissions after transcatheter aortic valve replacement

28 August 2020 (08:00 - 18:00)
Organised by:
Congress Presentation Part of: Valvular Heart Disease ePosters Intervention ESC Premium Access ESC Congress 2020

About the speaker

Photo
Mr Michael Hendrickson

The University of North Carolina at Chapel Hill., Chapel Hill (United States of America)

132 More presentations in this session

Presentation thumbnail
Left atrial dynamics in the hemodynamic response during exercise in patients with asymptomatic severe aortic stenosis: a cardiopulmonary imaging study
Doctor T. Sugimoto (Nagoya, JP)
Abstract Slides
Presentation thumbnail
Preserved Th2 lymphocytes improve prognosis of diabetic patients undergoing TAVR
Doctor J. Hoffmann (Frankfurt, DE)
Abstract Slides
Presentation thumbnail
Platelet membrane-coated nanoparticles target sclerotic aortic valves in ApoE-/- mice by multiple binding mechanisms under pathological shear stress
Doctor H. Yang (Shanghai, CN)
Abstract Slides
Presentation thumbnail
Long telomere length in circulating leukocytes is associated with monocytosis and poorer survival in patients with transcatheter aortic valve replacement
Doctor J. Hoffmann (Frankfurt, DE)
Abstract Slides
Presentation thumbnail
Longitudinal strain in patients with severe aortic regurgitation: superiority to ejection fraction for detection of myocardial dysfunction
Doctor J. Reil (Luebeck, DE)
Abstract Slides

Access the full session

Session thumbnail
Valvular Heart Disease ePosters

The Event

Event poster

ESC Congress 2020

28 August 2020 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Disparities in outcomes of Transcatheter Aortic Valve Replacement among patients with heart failure: a nationwide study in unites states from 2012-2018
22 May 2022
thumbnail
Congress Presentation
Incidence, causes and predictors of unplanned hospital readmission after percutaneous coronary intervention
31 August 2020
thumbnail
Congress Presentation
Clinical outcomes of early discharge in TAVI patients with new-onset LBBB
20 March 2026
thumbnail
Congress Session
ESC Paul Hugenholtz Lecture in Innovation
25 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources